Ma, Y., Yamazaki, T., Yang, H., Kepp, O., Galluzzi, L., Zitvogel, L., . . . Kroemer, G. (2013). Tumor necrosis factor is dispensable for the success of immunogenic anticancer chemotherapy. Landes Bioscience.
シカゴスタイル引用形Ma, Yuting, Takahiro Yamazaki, Heng Yang, Oliver Kepp, Lorenzo Galluzzi, Laurence Zitvogel, Mark J. Smyth, , Guido Kroemer. Tumor Necrosis Factor Is Dispensable for the Success of Immunogenic Anticancer Chemotherapy. Landes Bioscience, 2013.
MLA引用形式Ma, Yuting, et al. Tumor Necrosis Factor Is Dispensable for the Success of Immunogenic Anticancer Chemotherapy. Landes Bioscience, 2013.
警告: この引用は必ずしも正確ではありません.